Market Cap 65.29B
Revenue (ttm) 20.07B
Net Income (ttm) 2.90B
EPS (ttm) N/A
PE Ratio 13.39
Forward PE 13.08
Profit Margin 14.44%
Debt to Equity Ratio 0.50
Volume 8,201,676
Avg Vol 19,355,635
Day's Range N/A - N/A
Shares Out 1.45B
Stochastic %K 16%
Beta 0.57
Analysts Strong Sell
Price Target $60.30

Company Profile

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary syst...

Industry: Medical Devices
Sector: Healthcare
Phone: 508 683 4000
Address:
300 Boston Scientific Way, Marlborough, United States
Comox
Comox Sep. 16 at 6:17 PM
$BSX I’m gonna fucking puke. This stock is literally allergic to holding gains. Watch it close red.
0 · Reply
NeuroOne_IR
NeuroOne_IR Sep. 16 at 4:56 PM
$NMTC Our basivertebral nerve ablation program reflects our strategy of applying NeuroOne’s established technology and experience to additional therapeutic areas. We have completed the program’s regulatory strategy, with the system currently expected to follow a 510(k) pathway. Device optimization remains underway, including work to optimize lesion size. We are also engaged in advanced discussions with a potential tier-one strategic partner to develop and supply the access tools for the system as we continue evaluating this opportunity in chronic vertebrogenic lower back pain. $BSX $GMED
0 · Reply
FiveKegs
FiveKegs Sep. 16 at 3:31 PM
$BSX don’t see any catalyst that will spark growth over next 12-18 months. Slowing top line leading to organizational cuts which will help bottom line but decrease morale and lead to lower sales. Penumbra acquisition is expensive and will limit opportunities to buy additional bolt on acquisitions. This is dead money and most likely drifts lower or stays range bound.
2 · Reply
BluntForceOptions
BluntForceOptions Sep. 16 at 12:32 PM
$BSX Good morning, all. A quick word of perspective for long-term holders... Seeing heavy frustration across the feeds lately, which is completely understandable after a 58% haircut from the 52 wk high. But volatile washouts are where conviction is actually tested. In business, you get operational bottlenecks, regulatory friction, and sudden headwinds... it’s simply the price of admission. Taking profits and stepping aside tactically to manage risk--as I recently did--is one thing. Confusing near-term operational friction with permanent franchise impairment is quite another, and that's usually how investors get shaken out at the lows. No question, IMO, that the underlying franchise value here remains substantial. At ~3.2x sales, valuation is sitting near a decade trough (down from peaks of 8.6x). While WATCHMAN and electrophysiology have hit well-documented headwinds, the rest of the portfolio--roughly 75% of total revs--is still growing at around 6%, led by Interventional Cardiology (+15% in Q2). More importantly, operating margins have expanded for three consecutive years (from 16.6% up to 21% TTM). Multiple compression while profitability actually improves isn't a broken business; it’s washed-out sentiment. If your horizon is multi-year and you’ve done the fundamental homework, tune out the daily feed panic. In my experience, great franchises navigate the mud and come out stronger. As always, just my two cents. Wishing everyone solid discipline and great success navigating this cycle.
0 · Reply
DollarFlipper
DollarFlipper Sep. 16 at 11:39 AM
$BSX this is so f'n manipulated
1 · Reply
mickeyp_
mickeyp_ Sep. 15 at 9:20 PM
$BSX this will be a lot higher when who knows... no options!!! Buy it and look in a year or two
0 · Reply
Badinvestor51
Badinvestor51 Sep. 15 at 8:14 PM
$BSX dog shit close on a dog shit day. Fuck this one
0 · Reply
L4NDO
L4NDO Sep. 15 at 8:10 PM
$BSX someone wanna pin it at 50 end of week? Makes no sense even if spread only .30 of profit to be made if that’s the case. Wonder if volatile end of week and this whale; spread is gonna trade in and out on the way up. Still don’t know why this makes any sense? Lots of bio has had big days in terms of volume and cash, $UNH and $MRK had 500 billion in premium days Friday and Monday, anyone care to make sense of it?
1 · Reply
Badinvestor51
Badinvestor51 Sep. 15 at 6:43 PM
$BSX 2 steps forward, 1.5 steps back. Pointless pump yesterday
0 · Reply
bizness1957
bizness1957 Sep. 15 at 6:04 PM
$BSX $49 before ordering system issue which is now resolved
0 · Reply
Latest News on BSX
Boston Scientific Restores Key Operations After Cyberattack

Sep 10, 2026, 11:31 AM EDT - 6 days ago

Boston Scientific Restores Key Operations After Cyberattack


Boston Scientific put volume heavy and directionally bearish

2026-09-08T14:15:09.000Z - 8 days ago

Boston Scientific put volume heavy and directionally bearish


Boston Scientific Won't Meet Guidance Due to Cyberattack

Sep 8, 2026, 6:58 AM EDT - 8 days ago

Boston Scientific Won't Meet Guidance Due to Cyberattack


Penumbra, Inc. Reports Second Quarter 2026 Financial Results

Jul 30, 2026, 4:05 PM EDT - 6 weeks ago

Penumbra, Inc. Reports Second Quarter 2026 Financial Results

PEN


Boston Scientific Earnings Call Transcript: Q2 2026

Jul 29, 2026, 8:00 AM EDT - 7 weeks ago

Boston Scientific Earnings Call Transcript: Q2 2026


Boston Scientific Slides: Q2 2026

Jul 29, 2026, 8:00 AM EDT - 7 weeks ago

Boston Scientific Slides: Q2 2026


Boston Scientific Earnings release: Q2 2026

Jul 29, 2026, 8:00 AM EDT - 7 weeks ago

Boston Scientific Earnings release: Q2 2026


Boston Scientific Quarterly report: Q2 2026

Jul 29, 2026, 8:00 AM EDT - 7 weeks ago

Boston Scientific Quarterly report: Q2 2026


Boston Scientific Cuts Outlook Ahead of Restructuring

Jul 29, 2026, 7:23 AM EDT - 7 weeks ago

Boston Scientific Cuts Outlook Ahead of Restructuring


Boston Scientific announces results for second quarter 2026

Jul 29, 2026, 6:30 AM EDT - 7 weeks ago

Boston Scientific announces results for second quarter 2026


Belo Sun Announces Management Transition

Jun 8, 2026, 7:00 AM EDT - 3 months ago

Belo Sun Announces Management Transition


Belo Sun Announces Corporate Update

Jun 1, 2026, 7:30 AM EDT - 3 months ago

Belo Sun Announces Corporate Update


Belo Sun Provides Update on Ongoing Proceedings Before TRF-1

May 21, 2026, 7:00 AM EDT - 3 months ago

Belo Sun Provides Update on Ongoing Proceedings Before TRF-1


Boston Scientific Slides: Acquisition presentation

May 18, 2026, 7:00 AM EDT - 4 months ago

Boston Scientific Slides: Acquisition presentation


Boston Scientific announces strategic investment in MiRus LLC

May 18, 2026, 6:30 AM EDT - 4 months ago

Boston Scientific announces strategic investment in MiRus LLC


US FDA issues recall of Boston Scientific heart devices

May 7, 2026, 5:04 PM EDT - 4 months ago

US FDA issues recall of Boston Scientific heart devices


Belo Sun Mining Corp. Begins Trading on OTCQX

May 7, 2026, 12:48 PM EDT - 4 months ago

Belo Sun Mining Corp. Begins Trading on OTCQX


Penumbra, Inc. Reports First Quarter 2026 Financial Results

May 6, 2026, 4:05 PM EDT - 4 months ago

Penumbra, Inc. Reports First Quarter 2026 Financial Results

PEN


Belo Sun Provides Update on Volta Grande Gold Project

Apr 30, 2026, 6:04 PM EDT - 4 months ago

Belo Sun Provides Update on Volta Grande Gold Project


Boston Scientific Transcript: AGM 2026

Apr 30, 2026, 8:00 AM EDT - 4 months ago

Boston Scientific Transcript: AGM 2026


Boston Scientific Earnings Call Transcript: Q1 2026

Apr 22, 2026, 8:00 AM EDT - 4 months ago

Boston Scientific Earnings Call Transcript: Q1 2026


Boston Scientific Slides: Q1 2026

Apr 22, 2026, 8:00 AM EDT - 4 months ago

Boston Scientific Slides: Q1 2026


Boston Scientific Earnings release: Q1 2026

Apr 22, 2026, 8:00 AM EDT - 4 months ago

Boston Scientific Earnings release: Q1 2026


Boston Scientific Quarterly report: Q1 2026

Apr 22, 2026, 8:00 AM EDT - 4 months ago

Boston Scientific Quarterly report: Q1 2026


Boston Scientific Net Grows Sharply

Apr 22, 2026, 7:13 AM EDT - 4 months ago

Boston Scientific Net Grows Sharply


Boston Scientific announces results for first quarter 2026

Apr 22, 2026, 6:30 AM EDT - 4 months ago

Boston Scientific announces results for first quarter 2026


Boston Scientific Proxy statement: Proxy Filing

Mar 18, 2026, 8:00 AM EDT - 6 months ago

Boston Scientific Proxy statement: Proxy Filing


Boston Scientific Proxy statement: Proxy Filing

Mar 18, 2026, 8:00 AM EDT - 6 months ago

Boston Scientific Proxy statement: Proxy Filing


Comox
Comox Sep. 16 at 6:17 PM
$BSX I’m gonna fucking puke. This stock is literally allergic to holding gains. Watch it close red.
0 · Reply
NeuroOne_IR
NeuroOne_IR Sep. 16 at 4:56 PM
$NMTC Our basivertebral nerve ablation program reflects our strategy of applying NeuroOne’s established technology and experience to additional therapeutic areas. We have completed the program’s regulatory strategy, with the system currently expected to follow a 510(k) pathway. Device optimization remains underway, including work to optimize lesion size. We are also engaged in advanced discussions with a potential tier-one strategic partner to develop and supply the access tools for the system as we continue evaluating this opportunity in chronic vertebrogenic lower back pain. $BSX $GMED
0 · Reply
FiveKegs
FiveKegs Sep. 16 at 3:31 PM
$BSX don’t see any catalyst that will spark growth over next 12-18 months. Slowing top line leading to organizational cuts which will help bottom line but decrease morale and lead to lower sales. Penumbra acquisition is expensive and will limit opportunities to buy additional bolt on acquisitions. This is dead money and most likely drifts lower or stays range bound.
2 · Reply
BluntForceOptions
BluntForceOptions Sep. 16 at 12:32 PM
$BSX Good morning, all. A quick word of perspective for long-term holders... Seeing heavy frustration across the feeds lately, which is completely understandable after a 58% haircut from the 52 wk high. But volatile washouts are where conviction is actually tested. In business, you get operational bottlenecks, regulatory friction, and sudden headwinds... it’s simply the price of admission. Taking profits and stepping aside tactically to manage risk--as I recently did--is one thing. Confusing near-term operational friction with permanent franchise impairment is quite another, and that's usually how investors get shaken out at the lows. No question, IMO, that the underlying franchise value here remains substantial. At ~3.2x sales, valuation is sitting near a decade trough (down from peaks of 8.6x). While WATCHMAN and electrophysiology have hit well-documented headwinds, the rest of the portfolio--roughly 75% of total revs--is still growing at around 6%, led by Interventional Cardiology (+15% in Q2). More importantly, operating margins have expanded for three consecutive years (from 16.6% up to 21% TTM). Multiple compression while profitability actually improves isn't a broken business; it’s washed-out sentiment. If your horizon is multi-year and you’ve done the fundamental homework, tune out the daily feed panic. In my experience, great franchises navigate the mud and come out stronger. As always, just my two cents. Wishing everyone solid discipline and great success navigating this cycle.
0 · Reply
DollarFlipper
DollarFlipper Sep. 16 at 11:39 AM
$BSX this is so f'n manipulated
1 · Reply
mickeyp_
mickeyp_ Sep. 15 at 9:20 PM
$BSX this will be a lot higher when who knows... no options!!! Buy it and look in a year or two
0 · Reply
Badinvestor51
Badinvestor51 Sep. 15 at 8:14 PM
$BSX dog shit close on a dog shit day. Fuck this one
0 · Reply
L4NDO
L4NDO Sep. 15 at 8:10 PM
$BSX someone wanna pin it at 50 end of week? Makes no sense even if spread only .30 of profit to be made if that’s the case. Wonder if volatile end of week and this whale; spread is gonna trade in and out on the way up. Still don’t know why this makes any sense? Lots of bio has had big days in terms of volume and cash, $UNH and $MRK had 500 billion in premium days Friday and Monday, anyone care to make sense of it?
1 · Reply
Badinvestor51
Badinvestor51 Sep. 15 at 6:43 PM
$BSX 2 steps forward, 1.5 steps back. Pointless pump yesterday
0 · Reply
bizness1957
bizness1957 Sep. 15 at 6:04 PM
$BSX $49 before ordering system issue which is now resolved
0 · Reply
bizness1957
bizness1957 Sep. 15 at 6:01 PM
$BSX so under valued
0 · Reply
Badinvestor51
Badinvestor51 Sep. 15 at 4:06 PM
$BSX stock sucks man
0 · Reply
FOUNDRY123
FOUNDRY123 Sep. 15 at 2:45 PM
$BSX holding and looking for a strong rotation back to healthcare / biotech this fall
0 · Reply
Togdjclecj
Togdjclecj Sep. 15 at 2:25 PM
$BSX so lame.
0 · Reply
Comox
Comox Sep. 15 at 1:51 PM
$BSX What are you guys expecting tomorrow? Do you think the Fed’s decision is going to have a big impact on our stocks? What’s everyone’s take?
2 · Reply
DollarFlipper
DollarFlipper Sep. 15 at 1:29 PM
$BSX tanking?
1 · Reply
SuperGreenToday
SuperGreenToday Sep. 15 at 7:57 AM
$BSX Share Price: $45.05 Contract Selected: Oct 09, 2026 $45 Calls Buy Zone: $1.47 – $1.81 Target Zone: $2.36 – $2.89 Potential Upside: 52% ROI Time to Expiration: 23 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
rookie2016
rookie2016 Sep. 15 at 1:08 AM
$BSX Interesting..... https://x.com/pdicarlotrader/status/2099601977164362010?s=20
1 · Reply
OptionTradingWithSteve
OptionTradingWithSteve Sep. 15 at 1:01 AM
$BSX #BSX Bounced on long term support of 42.67, Today we GAPPED UP and is started a Bullish Harami on the Weekly chart. We have resistance at 45.16 but most likely go to 46.67 then next week go higher towards 49.15 then from there form a inverse H&S on that 49 area as the neckline, where we can potentially fire up towards 52-54 after that right shoulder fills out. But we are at the bottom of the inverse H&S and the Bullish harami, so ti will takes some time for 54, so lets watch out for 46-48 then 49 for now #OTWSWatchlist
1 · Reply
St0ckt0k101
St0ckt0k101 Sep. 14 at 10:17 PM
$BSX should be trading around $60-$62 not $45!! It’s been overdone for a while now‼️ all bad news priced in now. $70-$75 by the end of 2027 folks. This will be a nice turnaround by the end of next year✅
1 · Reply
Bullshyte
Bullshyte Sep. 14 at 9:22 PM
$BSX No brainer down here...
0 · Reply
AJTrading39
AJTrading39 Sep. 14 at 8:48 PM
$BSX $TTD big money flowed out of AI stocks into software and healthcare today
0 · Reply